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LAFUMA, J., CHMELEVSKY, D., CHAMEAUD, J., MORIN, M., MASSE, R., A N D KELLERER, 
A. M. Lung Carcinomas in Sprague-Dawley Rats after Exposure to Low Doses of Radon 
Daughters, Fission Neutrons, or 7 Rays. Radiat. Res. 118, 230-245 (1989). 
The effectiveness of radon-daughter inhalation and irradiation with fission neutrons and y 
rays in the induction of lung carcinomas in Sprague-Dawley rats at low doses is compared. 
Earlier reports which compared radon-daughter inhalations and neutron irradiations over a 
wider range of doses were based on dosimetry for the radon-daughter inhalations which has 
recently been found to be faulty. In the present analysis, low-dose experiments were designed to 
derive revised equivalence ratios between radon-daughter exposures, and fission neutron or 7 
irradiations. The equivalence is approximately 15 working level months (WLM) of radon daugh-
ters to 10 mGy of neutrons (the earlier value was 30 WLM to 10 mGy). The relative biological 
effectiveness (RBE) of neutrons is 50 or more at a 7-ray dose of 1 Gy. In these experiments with 
low doses and exposures, the lifetime incidences can be estimated from the raw incidences, while 
the derivation of the time dependence of the prevalence is essential for the estimation of RBE 
values and equivalence ratios. © 1989 Academic Press, Inc. 
I N T R O D U C T I O N 
A current study at C E A (Commissariat ä FEnergie Atomique) has been designed 
to compare induction of tumors in male Sprague-Dawley rats by exposure to radon 
daughters, fission neutrons, or 7 rays. Although the study, particularly the high-dose 
experiments, will not be complete for several years, current interest in the relative 
biological effectiveness (RBE) of low doses of densely ionizing radiations and espe-
cially in the cancerogenic potential of low doses of radon (J) makes it desirable to 
present the essential findings from the low-dose part of the study now. 
An added reason for this intermediate report is that it is necessary to make known 
changes in earlier results (2, 3) because these results were based on a faulty determina-
tion of the radon-daughter exposures. The revised dosimetry indicates lower radon-
daughter exposures in past experiments than previously assumed. This change is sub-
stantiated by the results which are reported here and which indicate an equivalence 
ratio of radon-daughter inhalation relative to neutrons somewhat lower than that 
0033-7587/89 $3.00 
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reported earlier. The equivalence ratio has been defined in (3) as the ratio of radon 
exposure and neutron dose that produce equal prevalences of lung carcinomas. 
MATERIALS AND METHODS 
Details of the investigations at CEA have been described in a number of reports (2-10). The experimental 
procedures may be summarized as follows. 
All experiments were performed with male Sprague-Dawley rats. The animals were 3 months old (±2 
weeks) at the beginning of the experiments. The animals were kept eight per cage under standard laboratory 
conditions (5). There was no random assignment of animals from different dose groups to cages, because 
the rats exposed to higher doses could not be kept with controls or with those animals that were exposed 
to lower doses. 
Animals were observed daily and remained in the experiment until moribund. The lungs were fixed in 
Bouin-Holland fluid when gross lesions were observed or when more subtle changes, such as granulomas, 
were detected by palpation. The lungs were then embedded in paraffin blocks. 
Serial sections, 20 fim apart, were taken until conspicuous lesions were detected; 5-^m sections were 
then taken from these lesions, and these were processed by conventional techniques. 
Radon-Daughter Inhalations 
The radon-daughter-inhalation studies were started first. They were part of a larger program to investi-
gate the effectiveness of various tv-emitters in inducing lung cancer in rats. 
The experiments were performed in an inhalation chamber which was modified in 1972 (for a descrip-
tion see (//)) . Measurements to determine the degree of equilibrium of radon with its daughters' were 
performed without animals in the inhalation chamber, and these measurements led to the conclusion that 
equilibrium was reached 3 h after the introduction of radon into the chamber. Only recently, after track 
detectors originally developed for the French uranium mines became available,2 3 did it become possible 
to measure radon-daughter concentrations during the actual exposures. The equilibrium factor was then 
seen to decrease substantially when animals were present in the chamber. 
The radon-daughter exposures had been calculated on the basis of the radon concentrations and the 
equilibrium factors. When the latter were found to be erroneous, this required simulations of the earlier 
1 It is difficult to estimate the absorbed dose to the lung resulting from a radon-daughter inhalation. 
Instead of dose, one therefore utilizes the concept of radon-daughter exposure. Ep. This quantity (see 
Appendix of Ref. (/)) is the product of the potential a-energy concentration cp. and the duration of the 
exposure. The quantity cp is defined as the sum of the total a-particle energy to be released by a mixture of 
short-lived radon daughters per unit volume of air. Its traditional unit, working level (WL), corresponds 
to 1.3 X 105 MeV/liter; it results from a concentration of 3.7 Bq of 2 2 2Rn/liter of air in radioactive equilib-
rium with its four short-lived daughter nuclides. A familiar unit of the radon-daughter exposure, Ep, is the 
working level month (WLM) where the time unit, working month, is defined as 170 h. In SI units 1 WLM 
equals 12.7 J m 3 s . 
The equilibrium factor, F, is the ratio of the actual value cp to the value that would prevail if the short-
lived radon daughters were in radioactive equilibrium with their mother nuclide, e.g., 2 2 2 Rn. Thus Fdeter-
mines the conversion factor from the activity concentration of 2 2 2 Rn in air to the radon-daughter exposure 
rate which equals the potential a-energy concentration, cp. One can express this in the following equation 
between cp in working level and the activity concentration, a, of radon in bequerel per cubic meter: 
cp = 0.27'\0-*-F.a. 
2 P. Zettwoog, State-of-the-art of the alpha individual dosimetry in France. Presented at the International 
Conference on Radiation Hazards in Mining: Control, Measurement, and Medical Aspects, Golden, Colo-
rado, October 4-9, 1981. 
3 S. Bernhard, J. F. Pineau, A. Rannou, and P. Zettwoog, One year of individual dosimetry in French 
mines. Presented at the International Conference on Occupational Radiation Safety in Mining, Toronto, 
Canada, October 14-18, 1984. 
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experimental conditions. These simulations have not been completed; furthermore, no simulations are 
possible for the exposure chamber which was used in the earlier inhalation experiments at higher doses. A 
decision has been made, therefore, to repeat the radon-inhalation experiments at intermediate and higher 
doses, and this will require several more years. The data for the present analysis are from two new experi-
ments at low radon-daughter exposures. 
No report concerning the revision of the radon-daughter dosimetry has been published, but one can 
make approximate corrections in the earlier results in terms of the equilibrium factors. The values range 
from 0.9 for the empty chamber, to 0.5 for the chamber with 50 animals, to a limit of 0.25 for the chamber 
with 500 animals. 
The experiments were always done with the ambient aerosol. Measurements of the particle size spectrum 
and of the unattached fraction of radon daughters were performed, although not routinely. The median 
particle size was estimated to be 0.8 ^m, and values for the unattached fraction4 between 5 to 10% were 
found (for a description of the instrumentation, see (12)). As various studies have shown (/. 13), the unat-
tached fraction significantly influences the dose to the upper part of the bronchial tree. The dose to the 
distal regions of the lungs is determined predominantly by the attached fraction. The attached fraction 
was, in the present experiments and according to the measurements, stable within a few percent. Masse 
(14) has argued that only the dose to the distal region of the lung is relevant in Sprague-Dawley rats, 
since most lung carcinomas originate distally after radon-daughter inhalation. This applies not only to the 
bronchoalveolar carcinomas but also to the bronchogenic carcinomas. In the present study no attempt was 
made to estimate, on the basis of the relevant parameters, the bronchial dose, and the reference parameter 
in the following is the radon-daughter exposure. 
Two experiments at low radon exposure are reported here. These experiments took place in 1981. The 
dosimetry was performed with track detectors.2 3 Basic data are given in Table I , which also contains infor-
mation for the neutron and 7-ray experiments. 
The rats were exposed to radon in sessions of 1 h, repeated approximately twice a week over 3.3 months 
for the group with 25 working level months (WLM) (42 sessions) and 6.3 months for the group with 50 
WLM (82 sessions). The potential a-energy concentration averaged 100 WL. In these experiments continu-
ous measurements of the potential a-energy concentration during inhalation were performed with three 
dosimeters positioned at three different heights in each of the two inhalation chambers. The exposure was 
set equal to the mean of the three dosimeter readings. A correction for the collection efficiency of 80% 
was applied. The results were compared for consistency with the exposure values obtained from radon-
concentration measurements (made by vial samplings) and from measurements of the equilibrium factor 
(by brief exposures of the track-etch detectors or by the Thomas method). 
Net a ran Ex peri} n en ts 
Technical details of the neutron experiments have been given previously (15. 16). The present analysis 
includes three neutron experiments. 
The whole-body neutron exposures were performed in 1979 at the biological irradiation facility of the 
reactor "Nereid" at CENFAR. This facility permitted the simultaneous exposure of two groups of 20 
animals each. The fission-neutron spectrum has been published earlier (15): the corresponding weighted 
and unweighted mean energies are 2.1 and 1.6 MeV. The neutron dosimetry was performed with polyethyl-
ene ionization chambers. Two ionization chambers were positioned in each cage, one on the front and one 
on the back. The ionization chambers were calibrated in the same neutron field against tissue-equivalent 
ionization chambers with walls 3 mm thick. The doses listed in Table I are mean values for the chambers 
and are rough estimates of the mean doses in the animals. A substantial 7-ray component was present in 
addition to the neutrons; it contributed about 25% to the total dose but is not included in the values shown 
in Table I . The quoted values are averages for animals in two groups of cages exposed simultaneously with 
somewhat different doses in each of these experiments (see Table I). The two groups in each experiment 
were pooled for the analysis and were assigned mean doses of 0.016, 0.08, and 0.40 Gy. Although the 
separate groups differ from their assigned doses by 25% in either direction, it was felt that the small number 
4 The unattached fraction here is the ratio of the unattached activity of 2 , 8Po to the total activity of 2 l 8Po. 
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TABLE I 
Synopsis of the Experiments 
No. of animals Mean time to 
examined Mean No. of death with lung 
(No. of animals lifetime animals No. of No. of No. of carcinoma 
at start (±SD) with lung bronchogenic bronchoalveolar lung (±SD) 
of experiment) (days) carcinomas carcinomas carcinomas sarcomas (days) 
Controls 579 ISA 5 4 1 1 901 
(586) (±149) 
Radon daughters 
25 WLM 497 730 11 8 3 764 
(501) (±135) (±119) 
50 WLM 496 737 19 16 3 — 742 
(500) (±126) (±89) 
V 993 30 24 6 — 
Fission neutrons3 
r 0.012 Gv 149 757 4 3 1 3 808 
(150) (±154) (±94) 
I 0.02 Gy 149 742 2 1 1 2 725 
(150) (±150) (±104) 
f 0.06 Gy 77 679 4 I 3 — 743 
(80) (±163) (±100) 
I O.lOGy 75 669 6 5 1 — 752 
(78) (±118) (±120) 
f 0.32 Gy 72 583 9 4 5 2 679 
(75) (±148) (±74) 
L 0.49 Gy 74 522 10 7 3 2 615 
(75) (±138) (±81) 
V 596 35 21 14 9 
7 rays 
r 1.0 Gv 204 700 8 3 5 2 807 
(204) (±146) (±95) 
I 1.0 Gy 301 706 6 2 4 3 835 
(301) (±146) (±52) 
3.0 Gy 120 648 7 5 3 2 741 
(120) (±160) (±105) 
y 625 21 10 12 7 
a In the analysis bracketed groups are pooled and the corresponding mean absorbed doses are used. 
of lung carcinomas in each group required the pooling of the observations. It must also be noted that the 
dose to different animals in a cage has an estimated standard deviation of about 10%, due to distance 
variations and due to mutual shielding of the animals. The durations of exposure for the neutron experi-
ments were 20 h for the 0.016-Gy experiment and 22 h for the others. 
Gamma-Ray Experiments 
The present analysis included three recent experiments with 7 rays. There were earlier studies with 7 
rays; however, they involved considerably higher doses and are therefore irrelevant to the comparison. 
Two of the recent experiments utilized the same dose of 1 Gy. The data for these experiments are listed 
separately in Table I , but the two experiments were pooled for the present analysis. 
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The exposures were performed with a 6 0Co irradiator; the duration of the irradiation was 14 h in all 
experiments. In each exposure, up to eight cages were exposed simultaneously, with 10 animals per cage. 
The dosimetry was performed with tissue-equivalent ionization chambers. A number of simulation stud-
ies were performed with groups of rat phantoms and LiF dosimeters to estimate the average doses in the 
rats under actual experimental conditions. It was concluded that these averages are about 15% less than 
the kerma values, and the adjusted values are quoted in Table I . 
Apart from the exposures, all experimental conditions were the same in the radon, neutron, and 7-ray 
studies. For practical reasons, animals from the same dose groups were caged together. 
Earlier estimates of the rate of spontaneous lung cancer incidence among this strain of Sprague-Dawley 
rats were based on scanty evidence. Several additional groups of control animals were therefore followed 
concurrently with the recent radon, neutron, and 7-ray studies. These observations were pooled into one 
control group, and are also given in Table I . 
The pathological classification of pulmonary malignancies was the same as that used earlier (2, 3). Lung 
carcinomas are recorded as bronchogenic or bronchoalveolar according to criteria stated by Masse (14). 
Table I gives the number of animals in each group with one or more tumors of the specified type. 
In the radon-inhalation studies no lung sarcoma has been found; this is consistent with the fact that the 
radon daughters do not reach the pulmonary connective tissue and the blood vessels in which sarcomas 
originate. In the neutron and 7-ray experiments nine and seven lung sarcomas have been observed; none 
were observed in an animal which developed a lung carcinoma. Compared to the one sarcoma observed 
in the control group, the incidences of sarcomas are highly significant (P < 10"3). The sarcomas were, with 
one possible exception, angiosarcomas which appeared to be rapidly lethal due to hemorrhage. To obtain 
dose dependencies one would have to pool angiosarcomas in all organs, and computational methods which 
account for lethality would have to be used. The lung sarcomas observed after neutron and 7 irradiations 
are tabulated in Table I , but otherwise are not part of the present analysis. 
CONVENTIONAL EVALUATION 
Figure 1 provides a synopsis of the data. The separate panels give the distributions 
of death and of animals bearing a lung carcinoma at autopsy. The data are given for 
successive 30-day intervals after the beginning of the exposure. 
In Fig. 2 the raw incidences, / , , are compared for the three radiations. The raw 
incidence is defined as 
Nj is the total number of animals that died in the dose group / whose lungs were 
examined histologically. nt is the number of animals among these with lung car-
cinomas. 
The raw incidence can be a poor measure of the cancerogenic effect when there is 
significant life shortening due to the irradiation. At the fairly low doses considered in 
this analysis, life shortening is of minor importance, and the comparisons in Fig. 2 
are therefore a meaningful indication of the relative effectiveness of the radiations in 
producing lung carcinomas. 
Nevertheless, there is some degree of life shortening in the neutron experiments. 
In order to take this into account and to utilize the experimental information fully, a 
more sophisticated analysis is required which makes use of the times to tumor detec-
tion and corrects for competing risks. This will also provide additional estimates of 
the lifetime incidences. 
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FIG. I . Distributions of the number of animals dying at specified times after exposure (blank columns), 
and distribution of the number of animals dying with a lung carcinoma (solid columns). The time scale is 
subdivided into 30-day intervals. Note the different ordinate scales for the number of deaths and the num-
ber of animals dying with lung carcinoma. 
COMPETING RISK CORRECTED ANALYSIS 
Before the method of analysis is described, it is necessary to state the definitions of 
the required quantities (see also, e.g., (2, 5)). 
The tumor rate, r(t\ is the probability per unit time at time / to incur the tumor; it 
is also termed hazard function. A closely related quantity is the cumulative rate, R(t) 
(also termed cumulative hazard function): 
R(t)= P' r{t')df. (2) 
Jo 
In the subsequent analysis these quantities, however essential, are less central than 
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FIG. 2. Raw incidences of lung carcinomas for the different radiation modalities. The standard errors 
are those for the binomial distribution. The lower abscissa does not relate to the radon-daughter exposures. 
a related quantity, the tumor prevalence, P(t). This is the probability at time / that 
the tumor is present. If tumors and mortality are unrelated, one has a simple relation 
between the prevalence and the cumulative rate: 
/>(/)= l -exp( - /? (r ) ) . (3) 
At small values P{t) and R{t) are identical; at larger values R(t) exceeds P(t) and, 
unlike P(t), it can exceed unity. 
If tumor rates (or tumor prevalences) are analyzed in a survival experiment, it is 
essential to know whether the tumors that are the cause of death are rapidly lethal, 
that is, the time between their initial growth and observation at autopsy is short. 
These tumors are in contrast to those observed incidentally at a later time when ani-
mals die for unrelated reasons or are sacrificed. Lung sarcomas are an example of a 
rapidly lethal tumor. For such tumors there are well-known methods of analysis. The 
analysis is more difficult for tumors which are incidentally observed, such as the lung 
carcinomas which cause, at least in the Sprague-Dawley rats, very little, if any, life 
shortening. For incidentally observed tumors there is no familiar method of analysis 
which would correspond, for example, to the proportional hazards analysis applied 
to the rapidly lethal tumors (77). 
A test has been recommended by Peto et ai (18) to identify a correlation between 
exposure (or dose) and incidence of neoplastic changes in the lungs. It has been ap-
plied to some of the radon experiments (79) on the basis of the old dosimetry and has 
shown a highly significant correlation. The present study is designed in addition to 
estimate the relative efficiency of the three radiations to induce lung carcinomas. In 
the previous studies methods have been developed for this purpose which also apply 
to the present analysis. Since they have been described previously (2, J), they are 
outlined only briefly here. 
Isotonic Regression 
To estimate the tumor prevalence in one dose group, one can utilize the method 
of isotonic regression. It is, for incidental tumors, the analog to the familiar Kaplan-
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FIG. 3. Estimates of prevalences obtained by isotonic regression for the different radiation modalities 
and dose groups. 
Meier estimate which applies to the rapidly lethal tumors. Isotonic regression is a 
nonparametric estimation, based merely on the plausible constraint that the preva-
lence be an increasing function of time. Figure 3 gives, in separate panels, the isotonic 
regression estimates of the lung carcinoma prevalence in the individual dose groups. 
Although some of the dose groups are large, there are, at these low doses, only a 
limited number of lung carcinomas. The magnitude of the statistical uncertainties 
therefore makes it difficult to assess numerically the relative efficiency of the different 
types of irradiation. For this reason it is necessary to utilize certain model assump-
tions to carry the analysis further. 
Joint Analysis of Different Dose Groups 
A common method of analysis is based on the choice of analytical expressions for 
the tumor rate or tumor prevalence as a function of dose and of time after exposure. 
However, such a procedure would be somewhat arbitrary in a case where the isotonic 
238 LAFUMA E T A L . 
regression estimates are not sufficiently precise to suggest, with adequate certainty, a 
proper analytical expression. 
In their analysis of the radon experiments, Gray et al (19) have used a Weibull 
model to account for the time dependence of all neoplastic changes in the lung. A 
nonparametric approach is used in the present study. It has the advantage that it 
requires fewer a priori assumptions and that the connection between the observed 
data and the derived prevalences is somewhat more transparent. In this approach it 
is sufficient to assume that the tumor prevalence is an unspecified increasing function 
of time after exposure, the so-called baseline function. This baseline function is as-
sumed to change according to a relatively simple model with increasing dose or with 
changing type of radiation. No analytical expression is postulated for the baseline 
function. As with isotonic regression, the only constraint is that it increases with time. 
Different assumptions are, of course, possible concerning the change of the baseline 
function with changing radiation or changing dose. As in the earlier analysis (2, J), 
two different models are utilized. One, the time-shift model, has been discussed in 
studies of life shortening and tumorigenesis after irradiation. The other, the time-
acceleration model, is, next to the proportional hazards model, the most frequently 
used model in survival or reliability analysis. In the shifted time model the prevalence 
has the same time dependence at any dose,5 D( (the index i refers to a dose group in 
one of the experiments), apart from a shift in time which depends on dose: 
P0(t) is termed the baseline function. s(Dj) are the time shifts; they are largest for the 
highest doses and are a measure for the earlier occurrence of the carcinomas. 
In the acceleration model the prevalence at a dose D{ is 
Again P0(t) is termed the baseline function. However, in this model the change of the 
prevalence function with dose is expressed not as a forward shift in time but as an 
acceleration of the cancerogenic process. The acceleration factors, a(Dj), depend on 
dose and type of radiation and are a measure for the faster occurrence of the carcino-
mas. No analytical expression is specified for the dependence on dose or on type of 
radiation of the time shifts, 5, or the acceleration factors, a. 
The first analysis of the radon studies (2) also employed the familiar "proportional 
hazards model." It was then found that, even with considerable numbers of animals 
and lung carcinomas, no one model appeared to fit the data substantially better than 
the others. Two models were nevertheless used in the present analysis to facilitate a 
judgment of the amount of bias introduced by the models. The time-shift and the 
acceleration models are computationally similar, and their parallel use is therefore 
particularly convenient. The proportional hazards model loses its advantage of com-
putational facility when it is employed with data for incidental tumors, and for this 
reason it is not applied in the present analysis. In the case of incidentally observed 
5 For simplicity the term dose and the symbol D are utilized in the subsequent considerations and 
equations, although they refer not only to the kerma of neutrons or y rays but also to the radon-daughter 
exposure, Ep. 
P(l, Dj) = P0(t + 5 ( A ) ) . (4) 
P(t, Di) = P(£a(Di).t). (5) 
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tumors, it is difficult to derive confidence intervals for the prevalences, and it was 
necessary to rely on an approximate procedure (see Appendix). As a check of consis-
tency of the estimated confidence intervals, the use of two models appeared to be an 
added advantage. 
The numerical analysis of the experimental data for either of the two models con-
sists in identifying that baseline function and those parameters s or a which agree best 
with the observed data. The quantitative measure for the agreement is the so-called 
likelihood, i.e., the relative probability that the observed frequencies of tumors at the 
given death times should have occurred under the assumption of a particular baseline 
function and a particular set of parameters s or a. It is important to note that the 
baseline function is not estimated from a control group, but that it is obtained from 
a simultaneous fit to all experimental groups, including the control group. The likeli-
hood equations have been given explicitly in the first study (2) and therefore need 
not be repeated here. As in the earlier work (2, 5), the numerical search for the best 
baseline function and best set of parameters, i.e., the ones with the highest likelihood, 
is performed by a nonlinear optimization algorithm (20).6 This algorithm is based on 
the method of steepest descent to find the maximum likelihood values of the baseline 
function (defined on a time grid) and of the time shifts (or the acceleration factors) 
under constraints imposed on all or part of the variables. 
In the earlier work the data included experiments over a broad range of doses with 
a corresponding range of tumor prevalences, and it therefore appeared justified to 
estimate the baseline function with a realistic, that is, a smooth, increasing function 
of time. In the earlier study, the constraint imposed on the prevalence function was 
a positive curvature (convexity from above) on a logarithmic scale of time. 
In the present work with low doses we have chosen the simpler constraint of mono-
tonicity of the prevalence function. In the computations the prevalence function P0(t) 
is defined on a time grid at 1 points (/ = 40). Under the constraint, the prevalences at 
consecutive grid points, / and / + 1, are monotonously increasing: P0(tj) < PoUi+\) 
(i = 1 to / ) . 
Results of the Maximum Likelihood Analysis 
One could derive separate fits for the three different radiation types. Somewhat 
different prevalence functions would then result, and a comparison would be difficult. 
Since there are no indications of systematic differences in the time course of preva-
lences for the different radiations, it appeared justified to postulate a joint baseline 
function for the different radiations and the various dose groups. This means that, in 
one simultaneous fit to all the data, a common baseline function, defined on a 30-
day grid of intervals, and parameters s or a are estimated (see Eqs. (4) and (5)). A 
comparison of the effect in different dose groups of different radiations can then be 
based merely on the estimated values s or a for these groups. The left panels in Fig. 4 
give the results of the joint fit for the shifted-time model. The right panels in Fig. 4 
6 Other optimization algorithms could be used (for a description of the various methods see {21)) to solve 
this or similar problems, i.e., to find the solution of a nonlinear equation under nonlinear (or linear) 
constraints on the variables. 
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FIG. 4. Estimates of prevalences based on joint maximum likelihood fits. The left panels give the results 
obtained with the time shift model (see Eq. (4)). The right panels give the results obtained with the time 
acceleration model (see Eq. (5)). 
give prevalences obtained in terms of the accelerated time model. In this case the 
dependencies run parallel on a logarithmic scale of time. As with the isotonic regres-
sion, the solutions are step functions, which is, of course, meaningless. However, as 
pointed out above, it was felt that little would be gained in this study by using numeri-
cal procedures which provide continuous solutions. This is the main difference from 
the earlier treatment (2, 3) where larger overall numbers of tumors justified more 
sophisticated constraints. The essential aim of the present analysis is the determina-
tion of the parameters s or a for the purpose of comparing the different radiations. 
Figure 5 gives the estimated relative time shifts, s, of the prevalence and the acceler-
ation factors, a, in two panels. The position of the points for the radon-daughter-
inhalation experiments relative to those for the neutron and 7-ray exposures is arbi-
trary, as there is no reliable conversion factor between the radon-daughter exposure 
and the absorbed dose in the lung. The different reference quantities are noted on 
the upper and lower border of the panels. The standard errors are approximations 
described in the Appendix; they do not include errors in the determination of doses. 
From the nature of the models it follows that an enhanced carcinogenic effect in 
one experiment relative to another is measured by the difference of the time shifts (or 
of the acceleration factors). The R B E of neutrons relative to 7 rays is then, according 
to its definition, equal to the ratio of the 7-ray dose to a neutron dose which results 
in the same time shift (or acceleration factor). 
From the results in Fig. 5 one estimates R B E values of neutrons relative to 7 rays 
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FIG. 5. Parameters obtained for the individual dose groups in the joint maximum likelihood fits. The 
lower panel gives the time shifts, s. The upper panel gives the acceleration factors, a. The values 5 and a 
are normalized to those for the control group. However, this is somewhat arbitrary because of the small 
number of only five lung carcinomas in the control group. More meaningful information is provided by 
the differences of the shift factors for different dose groups, and by the ratio of acceleration factors. The 
derivation of the standard errors is explained in the Appendix. 
between 30 and 40 at a neutron dose of 0.1 Gy, and those in excess of 50 at a neutron 
dose of 0.016 Gy. For the comparison between radon-daughter inhalations and neu-
tron or 7-ray exposures, one utilizes the concept of equivalence ratio which is analo-
gous to the R B E of neutrons versus radon or of y rays versus radon, except that one 
employs radon-daughter exposures instead of the insufficiently known absorbed dose 
produced by the radon daughters in the lung. The equivalence ratio of a radiation 
equals the ratio of a radon-daughter exposure to that dose of the radiation which 
produces equal prevalence of lung carcinomas. From the results in Fig. 5 one esti-
mates an equivalence ratio for fission neutrons versus radon daughters of about 15 
W L M to 10 mGy. For y rays versus radon daughters one estimates an equivalence 
ratio of about 25 W L M to 1 Gy. These estimated equivalence ratios refer to the lim-
ited range of radon-daughter exposures between 25 and 50 W L M which are employed 
in the present experiments. 
The estimates for the R B E and the equivalence ratios are in fair agreement with 
values which one would obtain from the raw incidences (Fig. 2). This may be fortu-
itous and does not imply that the maximum likelihood analysis is unnecessary. Nev-
ertheless, one concludes that the results are rather insensitive to the method of the 
analysis. 
The estimated prevalences, P(t, £>), can be utilized to derive standardized lifetime 
incidences (J), 
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TABLE II 
Estimated Lifetime Incidences of Lung Carcinomas 
Raw incidences 
Estimates based on Eg. (6) 
Time-shift model Acceleration model 
Radon daughters 
25 WLM 0.022 ± 0.007 0.028 0.032 
50 WLM 0.038 ± 0.009 0.039 0.035 
Fission neutrons 
0.018Gy 0.020 ± 0.008 0.026 0.031 
0.08 Gy 0.066 ±0.021 0.094 0.15 
0.40 Gy 0.130 ±0.030 0.23 0.25 
7 rays 
1 Gy 0.028 ± 0.007 0.021 0.028 
3Gy 0.058 ±0.022 0.089 0.17 
Controls 0.009 ± 0.004 0.009 0.016 
KD) = f P(t, D)m(t)du (6) 
where m(t)dt is the fraction of animals in the control group dying in the age interval t 
to / + dt (see bottom right panel in Fig. 1). Integrating over the prevalences in Fig. 4 
one obtains the estimated lifetime incidences which are compared to the raw inci-
dences with their standard errors in Table II. 
The raw incidences are substantially smaller than the standardized incidences for 
the higher neutron doses that produce substantial life shortening. But even without 
life shortening, the values need not agree. In the raw incidences all lung carcinomas 
are counted equally, regardless of the animal's age at death. In the maximum likeli-
hood analysis which underlies Eq. (6) the age is taken into account through the esti-
mation of the prevalence. 
CONCLUSIONS 
Our finding of an R B E for neutrons relative to y rays in excess of 50 at neutron 
doses of a few centigray is in substantial agreement with other observations which 
have been the basis of a recent proposal to increase the quality factors for neu-
trons (22). 
The equivalence ratio between radon-daughter inhalations and neutron irradia-
tions of about 15 W L M to 10 mGy differs by a factor of 2 from the earlier estimate 
of 30 W L M to 10 mGy. This reflects the revision of the radon-daughter dosimetry 
which has been discussed under Materials and Methods. The average absorbed dose 
produced by 15 W L M in the lung of the rat is uncertain. Harley (see discussion in 
(9)) has suggested that the value is close to that for man. With the estimated dose to 
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the lung of 5 to 10 mGy per W L M (/), one would translate the equivalence ratio of 
15 W L M to 10 mGy into an R B E of radon daughters versus neutrons of 0.07 to 0.14, 
and into an R B E of radon daughters versus 7 rays of 4 to 8. It may be noted that the 
quality factor of 20 has been recommended for both fission neutrons and a-particles 
(22). The present study suggests a substantially higher effectiveness of neutrons and— 
with the above tentative assumption—a lower effectiveness of radon daughters. 
In view of the complexities of the dose distribution in the lungs of rat or man, 
comparisons in terms of absorbed dose or dose equivalent are of doubtful validity. It 
is therefore more meaningful to consider directly the observed equivalence ratios 
between the radon-daughter exposure and the absorbed dose or dose equivalent of 
neutrons and 7 rays. It should be noted that the relative effectiveness of exposures to 
radon daughters compared to neutrons or 7 rays will be less if sarcomas of the lung 
are included because they are induced by neutrons and by 7 rays but not by the 
exposure to radon daughters. 
APPENDIX: DETERMINATION OF APPROXIMATE STANDARD ERRORS 
There are no established methods to derive standard errors for the parameters 
which are computed in the time-shift or acceleration model. Standard errors have 
therefore been derived by an approximative method which is outlined in the follow-
ing, and which avoids the need for more complicated "bootstrap" simulations. As 
described in the main part of the article, a simultaneous fit to all exposed groups has 
provided a baseline function, P0(t), of the prevalence. To take the example of the 
time-shift model, the estimated prevalence of lung carcinomas as a function of time 
after exposure is then P0(t + s). For brevity, the index which refers to the dose group 
is omitted here. The confidence interval of the time-shift parameter, 5, is obtained by 
considering different values of s' and by computing for each of the assumed values 
the expected number of lung carcinomas and its variance a2(sr), which would corre-
spond to the prevalence P0(t + s')\ the computations utilize the actually observed 
times of death in the specified groups. The standard error of s is then set equal to the 
range of values s' for which observed and expected number of carcinomas differ by 
not more than <r(s'). The variance for a specified value s' is obtained by the relation: 
As') = 2 N{tk)P0(tk + - P0(tk + s')). 
k 
The index k refers to the time; N(tk) is the number of animals having died in time k. 
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